Conventional therapy

Aug-95Surgery: ovarectomy and hysterectomy
8/95–12/95Chemotherapy: Taxol, cysplatin; and asplax 6 rounds completed
1998 or 1999Chemotherapy: Doxil, topotecan:11 months - completed therapy; followed by doxil 12 months-completed therapy
10/3/00Chemotherapy: erythrotecan and low dose taxol
2/1/01Surgery: laporascopy: reportedly did not reveal anything
4/19/01Chemotherapy: initiated due to lesions on liver presumably metastatic disease: campthzar/cysplatin

From: Appendix E: Additional Cases Reviewed

Cover of Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer.
Evidence Reports/Technology Assessments, No. 78.
Coulter I, Hardy M, Shekelle P, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.